Liver Cirrhosis: From Pathphysiology to Disease Management

Lieferzeit: Lieferbar innerhalb 14 Tagen

213,99 €

inkl. 7 % MwSt. zzgl. Versandkosten

Falk Symposium 162

ISBN: 1402086555
ISBN 13: 9781402086557
Herausgeber: J Bosch/Andrew Burroughs/F Lammert et al
Verlag: Springer Verlag GmbH
Umfang: xiii, 338 S.
Erscheinungsdatum: 29.05.2008
Auflage: 1/2008
Produktform: Gebunden/Hardback
Einband: GEB

Liver cirrhosis is a leading cause of morbidity and mortality worldwide. It is the fifth most common cause of death between the ages of 25 and 45. To date it is not possible to inhibit or reverse progression of cirrhosis in most patients. Accordingly, clinicians have to deal primarily with the various complications of cirrhosis, while liver transplantation is only available for selected patients. There has been tremendous progress in understanding liver fibrosis and cirrhosis since the last Falk Symposium devoted to this topic in 2000. This book, the proceedings of Falk Symposium No.162 entitled ‚Liver Cirrhosis: From Pathophysiology to Disease Management‘, held in Dresden, Germany, on October 13–14, 2007, focuses on the pathogenetic mechanisms of liver cirrhosis and clinical management of the complications. The first part of the book discusses liver fibrogenesis and the cellular responses to chronic liver injury as well as new non-invasive techniques for assessment of fibrosis in patients. The remainder focuses on preprimary and primary prophylaxis of variceal bleeding and therapy of other complications of cirrhosis. As in other Falk Symposium books, scientific and clinical experts offer a broad understanding and pave the way for interdisciplinary discussion, thus providing a blueprint for research and clinical management of liver cirrhosis, the most prevalent sequela of chronic liver diseases worldwide.

Artikelnummer: 1994514 Kategorie:

Beschreibung

The International Falk Symposium 162 in Dresden is a good example for the promises of history. Sixty years after the misery of the Second World War and the destruction of Dresden and 20 years after a long and threatening Cold War, scientists from more than 50 nations across the world met in a wonderfully reconstructed city to discuss a series of key lectures on the pathophysiology and clinical management of liver cirrhosis. Liver cirrhosis is a leading cause of morbidity and mortality worldwide. It is the fifth most common cause of death between the age of 25 and 45 years. To date, it is still not possible to inhibit or revert progression of cirrhosis in most patients. Accordingly, clinicians primarily deal with the various complications of cirrhosis, while liver transplantation is only available for selected patients. There has been tremendous progress in the understanding of liver fibrosis and cirrhosis since the last Falk Symposium devoted to this topic in 2000.

Das könnte Ihnen auch gefallen …